← Open Payments lookup

JOHN BRENNAN: Open Payments

NPI 1336123173 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,051 in 159 payments from 16 companies in 2025. Trend: 2023 $2,257 · 2024 $2,518 · 2025 $3,051

Food & beverage: $3,051
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$456
Otsuka America Pharmaceutical, Inc.17$397
Vanda Pharmaceuticals Inc.18$396
ABBVIE INC.22$336
Bausch Health US, LLC17$271
Lundbeck LLC13$258
Tris Pharma Inc11$255
Alkermes, Inc.8$195
Almatica Pharma LLC10$180
Noven Therapeutics, LLC4$66

Products named: REXULTI, CAPLYTA, FANAPT, VRAYLAR, Dyanavel XR, ARISTADA, LOREEV XR, WELLBUTRIN.

Industry payments across TX — which companies pay providers there.